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Patch testing in children, a useful investigation
P.E.BEATTIE AND M.S.LEWIS JONES
Dept. of Dermatology, Ninewells Hospital, Dundee, UK
Allergic contact dermatitis in children, until recently considered rare,
appears to be increasing in incidence. This may however reflect an
increased tendency to patch test children. The reported rate of
positive patch test reactions in children varies from 14–70% and of
relevant reactions from 20–92%. Most studies have involved limited
patch testing.
A retrospective case study of all children under the age of 16 years
who had been patch tested over a 3-year period in our department
was carried out. The children had a variety of indications for patch
testing including uncontrolled atopic dermatitis, non-atopic derma-
titis in localised areas such as the foot, scalp and oral region or a
history of reacting to foodstuffs or local anaesthetic creams.
There were 118 children (69 girls and 49 boys) aged from three to
15 years (median 11, IQR 8–14 years). Overall 67 (57%) children
had positive reactions that were of current or past relevance or
uncertain relevance. Testing to the standard series had been carried
out in 111 children, of whom 58 (52%) had a positive reaction. Sixty
children had been patch tested to medicaments of whom only six had
a positive reaction. None of the children patch tested to corticoster-
oids (n ¼ 47), shoe series (n ¼ 15), fragrance series (n ¼ 12),
cosmetic series (n ¼ 10) or rubber series (n ¼ 5), had a positive
reaction. One of five children tested to sunscreens reacted to Uvistat
and one of two tested to the dental battery reacted to Palladium. Four
children were tested to latex and did not react. Thirteen children were
tested to their own creams and five to their own shoes (one positive).
Open patch testing to food additives was indicated in ten children,
with positive reactions in all. Nickel was the most common allergen
(29%), as reported previously, followed by cobalt (9%), fragrance
(7%), lanolin (5%) and rubber chemicals. An irritant reaction to
cobalt was seen in 17%.
Our incidence of nickel allergy is higher than reports from
Glasgow1 and Sheffield2 and may reflect an increased incidence of
body piercing and nickel exposure at a young age or a higher pick-up
rate. Patch testing is a useful and worthwhile investigation in a
paediatric setting. The incidence of positive reactions is high and
avoidance of clinically relevant allergens may be a useful adjuvant to
topical therapy.
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Psychological problems and childhood atopic eczema
W.K.WOO, A.HIGGINS*, JR CORBETT AND E.A.BINGHAM
Department of Dermatology, *Department of Clinical Psychology, Royal
Victoria Hospital, Belfast, UK
This is a preliminary report of a series of twelve children with
difficult to control eczema where psychological interventions
helped. The children aged 2–12 years (mean age 6Æ3; five females)
were identified for psychological intervention on the basis that an
excessive itch-scratch cycle was associated with adjustment difficul-
ties (e.g., treatment non-compliance; behavioural problems; peer
relationship difficulties; anxiety). Psychological interventions used
included relaxation and distraction techniques, hypnosis, social
skills training, cognitive behaviour therapy, reinforcement schedules
and behaviour management strategies. Not only did these inter-
ventions have benefits for the proximal psychological problems
outlined above, but also for eczema control. In eight of the twelve
cases there were improvements. Two cases showed partial and
unsustained improvement and were referred to community services
because of non-illness related factors (i.e., Attention Deficit Hyper-
activity Disorder). There was an attrition rate of two out of twelve
across treatment. Our findings indicate the potential importance of
clinical psychology provision to paediatric dermatology services and
the need for more controlled systematic investigation.
Atopic dermatitis and the hygiene hypothesis:
a case control study
S.GIBBS*, H.SURRIDGE–, R.ADAMSON–, B.COHEN§,
G.BENTHAM AND R.READING–
*Dermatology Department, Ipswich Hospital, Ipswich IP4 5PD,–School of
Medicine, Health Policy and Practice, University of East Anglia, Norwich,
NR4 7TJ, §PHLS Central Public Health Laboratory, Colindale, London
NW9 5HT, Department of Environmental Science, University of East
Anglia, Norwich NR4 7TJ
The notion that a reduced exposure to microbial pathogens in early
life increases the chances of the expression of atopic disease has come
to be known as the hygiene hypothesis1. It has arisen from
observations of the rapidly rising prevalence of atopic diseases in
recent decades, the lower prevalence of atopy in lower socio-economic
groups and the lower prevalence of atopy with rising birth order.
Direct evidence for the hypothesis to date has been inconsistent.
This case-control study involving 602 children aged one to four
years in Norfolk, UK was designed to test the hypothesis with respect
to atopic dermatitis (AD). Cases and matched controls were selected
randomly from primary care databases and carefully defined using the
UK Diagnostic Criteria for AD. Exposure to infection during infancy
was measured with a range of direct and indirect methods including
assays of salivary antibodies to Epstein Barr virus and Varicella Zoster
virus, data extracted from primary care records and a questionnaire
administered to parents. Odds ratios (OR) for the effect of these
measures on AD were calculated using logistic regression with
adjustment for possible biological and social confounding factors.
Reduced odds of AD were associated with rising birth order (OR for
one older sibling 0Æ59, 95% CI 0Æ42 to 0Æ84 and for two or more older
siblings 0Æ49, 95% CI 0Æ31 to 0Æ77). None of the measures of exposure
to infection reduced the odds of AD, either in the unadjusted or
adjusted analyses. Some measures showed a weak association
between exposure and greater odds of AD, in the opposite direction
to that predicted by the hygiene hypothesis.
These data confirm a significantly reduced risk of AD in second and
subsequent siblings but this sibling effect of reduced odds with rising
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birth order does not appear to be explained by exposure to infection in
early life. More generally, these data cast doubt on the hygiene
hypothesis as a causal explanation for AD in young children.
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Contact urticaria to play dough: a possible sign of dietary
allergy
S.E.BARON AND C.MOSS
Department of Dermatology, Birmingham Children’s Hospital, Steelhouse
Lane, Birmingham
A 3-year-old boy, one of triplets, with eczema from 4 months of age
suffered a severe reaction at nursery. Whilst playing with play dough
his hands and forearms became immediately erythematous, swollen
and intensely itchy. The contact urticaria took 2 hours to subside.
There was no concomitant flaring of his eczema. Cautious re-
exposure identified red play dough as the cause. Because of the
possibility of allergy to red dyes in foods and medicines (to which he
had never been exposed), and future exposure to play dough, further
tests were carried out to identify the precise allergen.
Information about constituents of their products was obtained
from the manufacturers of Playdo, Early Learning Centre Soft
Stuff, Play Stuff and Ivanhoe play dough, Smarties and coloured
antibiotic syrups. The child then underwent open patch testing.
Smarties and Smartie-sized pieces of play dough were applied to the
forearm under micropore adhesive tape. Cotton wool soaked in the
antibiotic syrups was applied to the back under micropore adhesive
tape. After 20 minutes there was acute contact urticaria to the red
Playdo, the red Smartie and the red Cefaclor syrup. At 40 minutes
there was a milder reaction to the orange Playdo and orange
Smartie. The child was given oral chlorpheniramine and the
reactions settled over the next hour. The common ingredient of red
and orange Playdo and red and orange Smarties is the colourant
E124. Cefaclor syrup contains E129 as a colourant.
Open patch testing is widely used as a test for dietary allergy.
Therefore, in view of the positive tests, we advised avoidance both
topically and orally of all products containing E124 and E129. This is
the first report to date of a child presenting with contact urticaria to
these two additives. A history of play dough allergy may thus provide
useful information about dietary allergy.
Hydroxychloroquine therapy for Hydroa vacciniforme
V.S.RAMRAKHA-JONES AND D.BILSLAND
Department of Dermatology, Southern General Hospital, Glasgow
Hydroa vacciniforme is a rare idiopathic photodermatosis which
typically starts in childhood. It presents with an exposed-site
blistering eruption, which eventually heals with crusting and
scarring. Although spontaneous improvement occurs with age, the
mean duration of the disease is 9 years, and tends to be longer in
males1. Thus, it can severely impair the child’s quality of life
particularly in the summer months.
We report a case of a 10 year old boy with an 8 year history of
hydroa vacciniforme characterised by severe summer flare-ups, with
haemorrhagic blistering on the face and hands, often secondarily
infected. These disease flares failed to respond to various photopro-
tective measures including sunscreens, dietary fish oils, beta-caro-
tene, and narrowband UVB desensitisation.
For 4 months over the summer of this year (May to August) he
was treated with hydroxychloroquine at a dose of 100 mg daily
(3 mg/kg). This drug was tolerated well and has markedly reduced
the extent and severity of his blistering. Hydroxychloroquine has
been used in other photodermatoses, and there is one report of its use
in the treatment of hydroa vacciniforme.2
While the amount of ambient ultraviolet radiation is a variable
factor which can influence disease expression, we have been sufficiently
impressed with the therapeutic response to report this case.
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Childhood onset systemic lupus erythematosus
and complement deficiency
S.L.WALKER AND M.JUDGE
Dermatology Centre, Hope Hospital, Manchester
A 15-year-old boy presented with a 2-month history of lethargy and
a rash affecting his cheeks, nose and ears. His exercise tolerance had
diminished and he complained of painful knees, mouth ulcers and
scalp hair loss. Anorexia led to 6 kg weight loss. He was off school.
There is no significant past medical history. His mother’s cousin and
her son have systemic lupus erythematosus. His mother incidentally
has lichen planus.
Examination revealed discrete, livid infiltrated plaques on the
cheeks, nose and ears. There was associated hyperpigmentation. He
had a reticulate rash on the flexor aspects of his arms, vasculitic
lesions affecting the tips of his digits and brown, annular macules on
both palms. General examination including the musculoskeletal
system was normal.
The differential diagnosis was that of systemic lupus erythemato-
sus (SLE) with sarcoidosis a possibility.
He had a normochromic normocytic anaemia with a b 11Æ7, WCC
3Æ3 and a mild thrombocytopenia 129. ESR 24. Renal, liver, thyroid
function and a serum ACE level were normal. Antinuclear antibody
(ANA) was strongly positive 1/10 000 speckled. Ro antibody positive.
Double stranded DNA antibodies were borderline. Both C3 and C4
were markedly reduced 0Æ31 and 0Æ06 g/l respectively. C1 esterase
inhibitor, C1q and CH50 were all normal. Anticardiolipin and
antineutrophil cytoplasmic antibodies were negative. Urinalysis was
negative and has remained so throughout follow up. A skin biopsy
was performed which demonstrated features suggestive of lupus.
He was commenced on prednisolone 40 mg daily, topical beta-
methasone and sun block. His symptoms improved somewhat and
hydroxychloroquine 200 mg daily was added in as the steroid dose
was reduced. His symptoms have resolved, his ESR is normal and his
ANA titre is currently 1/1000. The hyperpigmentation persists but
he no longer requires a topical steroid. At 9 months follow up he is on
prednisolone 2Æ5 mg daily and hydroxychloroquine 200 mg daily.
The incidence of SLE among children under 15 is approximately
0Æ5 per 100 000 with a female to male ratio of 2:1 before puberty.
Heparin skin necrosis in a child
A.TAKWALE, K.BATTA, P.MILLER* AND C.MOSS
Department of Dermatology & Cardiology, *Birmingham Children’s
Hospital, Birmingham
Heparin-induced skin necrosis is a rare but potentially serious side
effect of anticoagulants. Dermatologists may be familiar with
coumarin skin necrosis in adults, but this adverse effect is less
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common with heparin and in children. We report a girl who
developed skin necrosis 3 hours after an intra-arterial heparin
injection given for a routine procedure.
A 5-year-old girl with an asymptomatic patent ductus arteriosus
(PDA) and a small ventricular septal defect underwent routine
catheterisation for closure of the PDA. She had been born at 29 weeks
gestation and required numerous interventions as a neonate, but was
now well apart from mild eczema. She received intra-arterial sodium
heparin (monoparin) 800 i.u at the beginning of the procedure, which
lasted for 90 minutes. Other drugs included: midazolam, propofol,
cisatracurium, fentanyl citrate and cefuroxime. Three hours later she
developed two very painful, purple, angular, clearly demarcated areas
on the buttocks. Immediate treatment included topical betamethasone
valerate, iv hydrocortisone and Chlorpheniramine maleate. The
central area of the larger lesion subsequently blistered and appeared
necrotic. The lesions gradually healed over the next two weeks with
minimal scarring and no recurrence.
When first examined by a dermatologist at 24 hours, the lesions
were thought to represent acute thermal burns. However investiga-
tion of the operating theatre revealed no possible contact with a heat
source. A local vasculitic or thrombotic process was suggested by the
lesional morphology and heparin seemed the most likely cause.
Heparin may induce platelet-aggregating immunoglobulins in
susceptible individuals causing a type III Arthus reaction manifesting
as thrombocytopenia, skin necrosis and thrombosis. Heparin IgG
antibodies and heparin-platelet factor 4 levels are usually raised but
were negative in our patient. Cutaneous necrosis secondary to
heparin administration may serve as a warning of the potentially
lethal complications of iv use. This child is likely to require
anticoagulation for future procedures. Fortunately alternative anti-
coagulants are available such as danaparoid sodium or r-hirudin.
Congenital linear porokeratotic eccrine ostial dermal duct
naevus
L.A.MURPHY AND D.J.ATHERTON
Paediatric Dermatology, St Johns Institute of Dermatology, London
Porokeratotic eccrine ostial and dermal duct naevus (PEODDN) is a
rare hamartomatous malformation centred on the eccrine sweat
duct. The distinctive histological feature is the presence of well-
formed cornoid lamellae in close association with eccrine sweat ducts.
The term porokeratotic eccrine ostial and dermal duct naevus
(PEODDN) was coined by Abel & Read (1980) to describe this clinical
entity1.
We report a patient with PEODDN who exhibited a long linear
hyperkeratotic lesion on the left lower limb which developed during
the weeks after birth, and which extended from the buttock to the
proximal nail fold of the great toe. In addition there were scattered
hyperkeratotic lesions on the left palm, comprising groups of comedo-
like papules. The child was systemically well and had been a full-term
normal spontaneous delivery; parents were nonconsanguinous and
there was no relevant family history.
Two distinctive types of lesion are recognised clinically in
PEODDN, both of which are demonstrated in our patient: palmo-
plantar papules resembling comedones, whose central pits are
occluded with keratin plugs, and hyperkeratotic plaques which
resemble linear verrucous epidermal naevi. Histologically the hall-
mark of the condition is the close association of cornoid lamellae with
eccrine sweat apparatus.
This rare hamartoma is considered to arise from the eccrine duct2.
It has been suggested that PEODNN could represent an abnormal
keratinizing epidermal invagination rather than an abnormally
dilated and parakeratotic acrosyringium and dermal duct.
References
1 Abell E & Read SI. Porokeratotic eccrine ostial and dermal duct
naevus. Br J Dermatol 1980; 103: 435–41
2 Begman R, Lichtig C, Cohen A, Friedman-Birnbaum R. Porokera-
totic eccrine ostial and dermal duct naevus. An abnormal kerati-
nizing epidermal invagination or a dilated, porokeratotically
plugged acrosyringium and dermal duct? Am J Dermatopathol
1992; 14: 319–22
A case of lipoid proteinosis with molecular diagnosis
T.HAMADA, RAJ EADY AND J.A.MCGRATH
Department of Cell and Molecular Pathology, St John’s Institute of
Dermatology, St Thomas Hospital, London, UK
Lipoid proteinosis (OMIM 247100) is a rare, autosomal recessive
disorder characterized by skin scarring and infiltration as well as vocal
cord thickening leading to hoarseness. Histologically, there is wide-
spread deposition of hyaline material and disruption/reduplication of
basement membrane. Recently, we have mapped the disorder to 1q21
and identified the gene for lipoid proteinosis as the extracellular matrix
protein 1 gene, ECM11 Ten different homozygous mutations have now
been identified in patients from a number of different countries. In
each case, the sequence changes comprise nonsense, frameshift, or
internal deletion mutations leading to loss-of-function of ECM11.
We report here the case of a 14-year-old Pakistani boy with
consanguinous parents, whom we have followed at St Thomas
Hospital since early childhood. He has had progressive hoarseness
since early infancy. Skin signs are relatively mild. There is diffuse skin
thickening, which also affects the tongue, and pitted scarring on the
face and upper trunk. Molecular analysis revealed a homozygous C>T
transition at nucleotide 1036 in exon 7 of ECM1 ; the mutation is
designated Q346X, which is predicted to result in loss of function of
the ECM1a isoform.
Although the precise function of ECM1 is not known, molecular
analysis of ECM1 not only improves diagnostic accuracy and make
feasible carrier screening and DNA-based prenatal diagnosis in lipoid
proteinosis, but also indicates the potential importance of ECM1 in
several aspects of normal skin biology, including wound healing.
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Transient Bullous Disease of the Newborn may be severe
S.E.BARON*, F.SHAH*, RAJ EADY AND C.MOSS*
*Department of Dermatology, Birmingham Children’s Hospital and St
John’s Institute of Dermatology, St Thomas’s Hospital, London
Transient bullous disease of the newborn is a rare form of recessive
dystrophic epidermolysis bullosa in which type VII collagen is intially
retained in epidermal cells, only later reaching its normal position at
the dermo-epidermal junction. Affected infants have a relatively good
prognosis, often with complete resolution of blistering by 12 months
of age. However, as our patient illustrates, the neonatal presentation
can be very severe.
A full-term female infant, born to consanguinous Pakistani parents,
presented at birth with extensive skin loss affecting knees, shins,
forearms and feet. She had normal nails and a normal cry. Over the
first week she developed further blisters on the abdomen and buttock
and later in her mouth. A diagnostic shave biopsy of a rubbed area
of unaffected skin, taken at 7 days, showed widespread separation
along the dermo-epidermal junction under light microscopy.
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Electron-microscopy showed that the split was immediately beneath
the lamina densa, with perinuclear inclusions in numerous basal
keratinocytes. Immunoelectron microscopy identified the inclusions
as type VII collagen, while the normal linear staining for type VII
collagen at the dermo-epidermal junction was absent. Laminin 5
(GB3) staining was normal and linear. These changes are character-
istic of transient bullous disease of the newborn. The denuded areas of
skin healed over the first two months, with minimal further blistering.
Transient bullous disease of the newborn was first described by
Hashimoto in 1985. Whilst in the early neonatal period the blistering
and erosions can be severe (fatal in one case), by 12 months of age
the infants are usually free of blisters. Sequential skin biopsies of such
children show a gradual progression of type VII collagen from its
early intraepidermal position to a more normal unbroken band at the
dermo-epidermal junction, mirroring the clinical improvement. It is
therefore necessary to take an early biopsy, preferably within the first
2 weeks of life in order to recognize this variant of dystrophic
epidermolysis bullosa.
References
1 Hashimoto K, Burk JD, Bale GF et al. Transient bullous dermolysis
of the newborn. Arch Dermatol 1985; 121: 1429–38.
2 Phillips RJ, Harper JI, Lake BD. Intraepidermal collagen type VII in
dystrophic epidermaolysis bullosa: report of five new cases. Br J
Dermatol 1992; 126: 222–230.
1 2 9 4 A B S T R A C T S
 2003 British Association of Dermatologists, British Journal of Dermatology, 148, 1291–1294
